Clinical Trials · NCT02425722
A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Astellas Pharma Inc
- Enrollment
- 383
- Start date
- Apr 2015
- Locations
- 50 sites, Japan
- Primary endpoint
- Change in weekly average of SBM frequency